Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival (Q40630645)

22 September 2017

title

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival (English)

1 reference

22 September 2017

0 references

invasive aspergillosis

1 reference

Groll AH

1 reference

22 September 2017

Kurz M

1 reference

22 September 2017

Schneider W

1 reference

22 September 2017

Witt V

1 reference

22 September 2017

Schmidt H

1 reference

22 September 2017

Schneider M

1 reference

22 September 2017

Schwabe D

1 reference

22 September 2017

publication date

1 January 1999

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

issue

7-8

1 reference

22 September 2017

page(s)

431-442

1 reference

Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

An outbreak of aspergillosis in children with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

High Dose Cyclophosphamide with Carboplatin: A Tolerable Regimen Suitable for Dose Intensification in Children with Solid Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Successful treatment of pulmonary and cerebral aspergillosis in an immunosuppressed child

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Invasive aspergillosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Favorable outcome of invasive aspergillosis in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Fungal sinusitis in immunocompromised children with neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Invasive Aspergillus sinusitis in pediatric bone marrow transplant patients. Evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

A Comparative Review of Colony-Stimulating Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

The surgical management of fungal pulmonary infections in children with acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Operation for cavitating invasive pulmonary aspergillosis in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Impact of previous aspergillosis on the outcome of bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00496.X

10.1046/J.1439-0507.1999.00496.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference